BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...

Kahimmune Therapeutics has signed a scientific collaboration agreement with Gustave Roussy to support the selection and ...

Clesrovimab is first monoclonal antibody offering a single fixed dose for infants The UK’s Medicines & Healthcare Products Regulatory Agency has granted marketing authorisation to Enflonsia ...

AstraZeneca’s Saphnelo has been approved in the US for self‑administration as a once‑weekly autoinjector, the Saphnelo Pen, for adults with systemic lupus erythematosus receiving standard therapy. The ...

Theolytics has dosed the first patient in a phase 1 clinical trial investigating intraperitoneal administration of THEO‑260 for women with platinum‑resistant ovarian cancer. T ...

Asgard Therapeutics will present new preclinical data on its lead asset AT‑108 in an oral presentation at the ASGCT Annual ...

A British inquiry into the use of chemotherapy to treat seriously ill cancer patients has found the treatment caused or hastened death in 27% of cases. A British inquiry into the use of chemotherapy ...

NICE recommends non‑hormonal therapy for moderate to severe vasomotor symptoms Astellas Pharma has announced that the National Institute for Health and Care Excellence has issued Final Draft Guidance ...

New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer a longer progression free survival for patients with newly diagnosed ...

Herantis Pharma has dosed the first patients in the final cohort of its phase 1b clinical trial assessing HER-096, a disease-modifying treatment for Parkinson’s disease. The study aims to evaluate the ...